Arkolith/Insider Trading/IMGN/Form 4

Vasconcelles Michael

EVP R&D & MEDICAL AFFAIRSImmunoGen, Inc. (IMGN) · full profile →Form 4 · filed Feb 12, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2024Disposed to issuer(D)1K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2024Disposed to issuer(D)51K——0
Feb 12, 2024Disposed to issuer(D)960K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-014692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML